Search Results - "Raso, M. Gabriela"
-
1
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome
Published in Cancer (01-06-2012)“…BACKGROUND: Lung adenocarcinoma is histologically heterogeneous and has 5 distinct histologic growth patterns: lepidic, acinar, papillary, micropapillary, and…”
Get full text
Journal Article -
2
Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma
Published in Clinical cancer research (15-11-2013)“…New prognostic markers to guide treatment decisions in early stage non-small cell lung cancer are necessary to improve patient outcomes. In this report, we…”
Get full text
Journal Article -
3
Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis
Published in Development (Cambridge) (01-10-2009)“…Mitogen-inducible gene 6 [ Mig-6 ; Errfi1 (ErbB receptor feedback inhibitor 1); RALT (receptor-associated late transducer); gene 33 ] is a ubiquitously…”
Get full text
Journal Article -
4
Primary Oncocytic Adenocarcinomas of the Lung: A Clinicopathologic, Immunohistochemical, and Molecular Biologic Analysis of 16 Cases
Published in American journal of clinical pathology (2010)“…Sixteen cases of primary oncocytic adenocarcinomas of the lung are reported. The patients were 11 women and 5 men between the ages of 47 and 81 years (median,…”
Get full text
Journal Article -
5
Effective Drug Delivery, In Vitro and In Vivo, by Carbon-Based Nanovectors Noncovalently Loaded with Unmodified Paclitaxel
Published in ACS nano (24-08-2010)“…Many new drugs have low aqueous solubility and high therapeutic efficacy. Paclitaxel (PTX) is a classic example of this type of compound. Here we show that…”
Get full text
Journal Article -
6
Abstract 272: Nanoscale high-throughput quantitative RT-PCR for the characterization of targeted-therapy related molecular biomarkers from recurrent and non-recurrent NSCLC tissues
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Currently, there are no good biomarkers to predict targeted therapy outcomes for patients whose cancers recur vs. those that do not. Technology limitations…”
Get full text
Journal Article -
7
Abstract 794: Targeted-therapy related molecular biomarker characterization in NSCLC smokers and never-smokers by a novel qRT-PCR for microdissected tissues methodology
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Several studies have focused on the identification of biologic markers that predict early recurrence and death in patients with non-small cell lung cancer…”
Get full text
Journal Article -
8
Effective Drug Delivery, In Vitro and In Vivo, by Carbon-Based Nanovectors Noncovalently Loaded with Unmodified Paclitaxel
Published in ACS nano (28-09-2010)Get full text
Journal Article -
9
Effective Drug Delivery, in vitro and in vivo, By Carbon-Based Nanovectors Non-Covalently Loaded With Unmodified Paclitaxel
Published in ACS nano (24-08-2010)“…Many new drugs have low aqueous solubility and high therapeutic efficacy. Paclitaxel (PTX) is a classic example of this type of compound. Here we show that…”
Get full text
Journal Article -
10
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets
Published in JTO clinical and research reports (01-02-2024)“…NSCLC transformation to SCLC has been best characterized with EGFR-mutant NSCLC, with emerging case reports seen in ALK, RET, and KRAS-altered NSCLC. Previous…”
Get full text
Journal Article -
11
Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases
Published in Human pathology (01-04-2011)“…Summary Oncocytic neuroendocrine tumor of the lung is rare. To reveal the clinicopathologic features of oncocytic neuroendocrine tumor, we reviewed surgical…”
Get full text
Journal Article